What will you learn?
Getting from millions of sequences to a diverse set of developable antibodies with the right therapeutic properties can be incredibly challenging, time-consuming, and requires significant software and computational resources. In this session, we will break down how you can:
- Easily perform clustering, phylogeny, and exposed liability analyses in a secure, scalable environment
- Accelerate antibody selection by exploring multiple characteristics from sequence, assay, and in silico predicted data
- Leverage exposed liability predictions and developability profiles to de-risk candidate selection
